# Ivabradine in the Acute Management of Cardiogenic Shock

> **NCT07714746** · PHASE3 · RECRUITING · sponsor: **National Institute of Cardiovascular Diseases, Pakistan** · enrollment: 200 (estimated)

## Conditions studied

- Cardiogenic Shock Post Myocardial Infarction

## Interventions

- **DRUG:** Ivabradine 5mg Tab
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT07714746
- **Lead sponsor:** National Institute of Cardiovascular Diseases, Pakistan
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-20
- **Primary completion:** 2027-05-31
- **Final completion:** 2027-05-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07714746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07714746, "Ivabradine in the Acute Management of Cardiogenic Shock". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07714746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*